Nyumbani » Wote » Utabiri wa Hisa » Vertex Pharmaceuticals Incorporated Common Stock Utabiri

Vertex Pharmaceuticals Incorporated Common Stock Utabiri: Kesho, Wiki, Mwezi, Miaka 5

Imesasishwa: April 22 · 2026 at 07:03 UTC

From

▼ -0.59%Market Cap $111.09B · Technical analysis Bearish · Focus area Price + volatility

Muhtasari wa Utabiri

Muda uliopangwa	Bei Iliyotabiriwa	Zamani	Kihistoria	Maarifa
Kesho	$433.50 ▼ -0.71%	Jana	$437.89 ▲ +0.30%	Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.
Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.
Wiki	$426.99 ▼ -2.20%	Wiki Iliyopita	$440.62 ▲ +0.92%	The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.
The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.
Mwezi	$416.13 ▼ -4.69%	Mwezi uliopita	$445.18 ▲ +1.97%	The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Mwaka	$399.87 ▼ -8.41%	Mwaka jana	$452.01 ▲ +3.53%	The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
Miaka 5	$361.75 ▼ -17.14%	Miaka 5 Iliyopita	$468.02 ▲ +7.20%	The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Kesho$433.50▼ -0.71%

Jana$437.89▲ +0.30%

Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.

Wiki$426.99▼ -2.20%

Wiki Iliyopita$440.62▲ +0.92%

The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.

Mwezi$416.13▼ -4.69%

Mwezi uliopita$445.18▲ +1.97%

The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Mwaka$399.87▼ -8.41%

Mwaka jana$452.01▲ +3.53%

The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

Miaka 5$361.75▼ -17.14%

Miaka 5 Iliyopita$468.02▲ +7.20%

The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Chati ya Bei

KihistoriaUtabiriBullishBearish

Uchambuzi wa Kiufundi

Bearish

Bullish

Si upande wowote

Bearish

Viashiria Muhimu

Kiashiria	Thamani	Mawimbi
Price	$436.59	Mid
Daily Change	-0.59%	Below
Volatility Cap	20.0%	Mid
Confidence	58%	Below
Data Source	nasdaq-screener	Mid

Data ya Kihistoria

Current$436.59

Daily Change-0.59%

Market Cap$111.09B

Sourcenasdaq-screener

Current	$436.59	Daily Change	-0.59%
Market Cap	$111.09B	Source	nasdaq-screener

Usaidizi & Viwango vya Upinzani

$423.49Support 1

$436.59Ya sasa

$449.69Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Bei Milestones

Viwango muhimu na muktadha wa kihistoria

Current$436.59Live reference price

Used as the anchor for generated forecast calculations.

Next Month$416.13Model projection-4.69%

Directional scenario based on capped drift.

Usahihi wa Utabiri

Jinsi mtindo wetu umefanya

58%

Mwelekeo

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Kanuni zetu husawazishwa upya kila wiki kwa kutumia hatua ya hivi punde ya bei, hali tete na viashiria vya viashirio. Usahihi hutofautiana kulingana na muda - kasi ya muda mfupi inaaminika zaidi kuliko makadirio ya muda mrefu.

Short term

58%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Matukio ya Uwekezaji

Ikiwa utawekeza $1,000 katika VRTX leo

Bullish Scenario

$458.42

+5.00% from current

Bei Lengwa$458.42

MazingiraUpside momentum

Uwezekano50%

Base Scenario

$416.13

-4.69%

Bei Lengwa$416.13

MazingiraCapped drift

Uwezekano58%

Bearish Scenario

$414.76

-5.00% from current

Bei Lengwa$414.76

MazingiraVolatility drawdown

Uwezekano42%

Msingi: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Mambo ya Utabiri

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 40/100

24H drift-0.71%

7D drift-2.20%

30D drift-4.69%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 35/100

1M outlook-4.69%

1Y outlook-8.41%

5Y outlook-17.14%

Maswali Yanayoulizwa Mara Kwa Mara

Q What is the Vertex Pharmaceuticals Incorporated Common Stock (VRTX) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Vertex Pharmaceuticals Incorporated Common Stock is projected near $433.50 versus the current reference around $436.59. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for VRTX?

The weekly Vertex Pharmaceuticals Incorporated Common Stock model points to $426.99, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Vertex Pharmaceuticals Incorporated Common Stock 1-month and 1-year targets?

The Vertex Pharmaceuticals Incorporated Common Stock 1-month target is $416.13 (-4.69%), while the 1-year target is $399.87 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Vertex Pharmaceuticals Incorporated Common Stock 5-year scenario differ from short-term rows?

The Vertex Pharmaceuticals Incorporated Common Stock long-horizon scenario sits near $361.75 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are VRTX support and resistance zones right now?

For Vertex Pharmaceuticals Incorporated Common Stock, nearest resistance is around $423.49, while nearest support is around $449.69. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Vertex Pharmaceuticals Incorporated Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.